v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Apr. 05, 2026
Mar. 30, 2025
Cash flows from operating activities:    
Net income $ 51,704 $ 23,603
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Stock-based compensation expense 11,933 9,939
Depreciation of property, plant, and equipment 4,703 5,306
Amortization of intangible assets 2,532 2,628
Excess and obsolete inventory charges 364 197
Loss on sale of business, net of transaction costs 1,539 0
Deferred income taxes 4,740 (4,689)
Other adjustments (380) (188)
Accounts receivable (23,711) (17,183)
Unbilled revenue 593 307
Inventories 8 5,474
Prepaid expenses and other current assets (12,212) 2,526
Accounts payable 9,390 4,996
Accrued expenses (13,554) (6,055)
Accrued income taxes (2,905) (3,153)
Deferred revenue and customer deposits 12,889 14,761
Other (2,540) 2,033
Net cash provided by (used in) operating activities 45,093 40,502
Cash flows from investing activities:    
Purchases of investments (47,013) (113,297)
Maturities and sales of investments 39,042 148,885
Net proceeds from sale of business 11,519 0
Purchases of property, plant, and equipment, net of proceeds (2,757) (2,501)
Net cash provided by (used in) investing activities 791 33,087
Cash flows from financing activities:    
Net payments from issuance of common stock under stock plans 44,290 (2,587)
Repurchase of common stock (98,995) (102,233)
Payment of dividends (14,196) (13,550)
Net cash provided by (used in) financing activities (68,901) (118,370)
Effect of foreign exchange rate changes on cash and cash equivalents (2,565) 2,431
Net change in cash and cash equivalents (25,582) (42,350)
Cash and cash equivalents at beginning of period 262,925 186,094
Cash and cash equivalents at end of period $ 237,343 $ 143,744